(Q43647687)

25 November 2017

title

Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies (English)

1 reference

25 November 2017

Said T

1

1 reference

25 November 2017

Nampoory MR

2

1 reference

25 November 2017

Johny KV

3

1 reference

25 November 2017

Pacsa AS

4

1 reference

25 November 2017

Mini Abraham P

5

1 reference

25 November 2017

Nair MP

6

1 reference

25 November 2017

Abdel-Haleem M

7

1 reference

25 November 2017

Samhan M

8

1 reference

25 November 2017

Al-Mousawi M

9

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Transplantation Proceedings

25 November 2017

published in

1 reference

25 November 2017

volume

36

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

1847-1849

1 reference

Management and prevention of cytomegalovirus infection after renal transplantation

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.021

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.021

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.021

Cytomegalovirus infection in kidney transplant recipients: early diagnosis and monitoring of antiviral therapy by the antigenemia assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.021

Prevention and treatment of cytomegalovirus infection in organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.021

Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.021

Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.021

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.021

Epidemiology of cytomegalovirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.07.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSPROCEED.2004.07.021

1 reference

25 November 2017

1 reference